Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...

| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...

Merck & Co (MSD) and Eisai are set to discontinue their Phase III clinical trial for unresectable, non‑metastatic ...

The FDA denied approving DCA to treat a rare disorder called PDCD. The Higbees are urging the agency to reconsider.

In contrast, a DL model can offer precise, AI-generated coding suggestions for adverse events and concomitant medications at up to 99% accuracy. The model can adapt to different scenarios, removing ...

Ministers and the NHS have repeatedly said one in five children leave primary school obese—but data obtained by Full Fact ...

Ann Kan's role as a senior statistical analyst at NUDACC allows her to blend a skillset that optimally supports multisite ...

Researchers in Kingston, Ont., are embarking upon a clinical trial that will look at whether very small doses of psilocybin — ...

Significant increases in risk were observed for all autoimmune diseases except Graves disease and autoimmune hepatitis ...

The software includes scattergrams comparing attempted vs achieved corrections, which can be used to refine surgical ...

It was the best of interviews, it was the worst of interviews. At times I was born aloft on the wings of enlightenment, other ...

At an interim analysis of the phase 3 LITESPARK-011 trial (NCT04586231), the oral combination of belzutifan (Welireg) plus ...